Mills is the Wayne and Julie Drinkward Endowed Chair in Precision Oncology, Director of Precision Oncology, Director of SMMART Trials and Professor in Cell, Development and Cancer Biology in the Knight Cancer Institute at Oregon Health & Science University.
[1] Mills received his BS in 1975, MD in 1977, and PhD in 1984, all from the University of Alberta, Edmonton.
[1] He held multiple leadership positions at the MD Anderson Cancer Center including Chair of Systems Biology, Director of the Kleberg Center for Molecular Markers and was co Director of the Khalifa Institute for Personalized Cancer Therapy.
He was recruited to the Knight Cancer Institute as Director of Precision Oncology in October 2017.
Along with his research in PI3K, he focuses on signaling pathways and markers for targeted therapy.